CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Macleods Pharmaceuticals Ltd recalls Levothyroxine Sodium Tablets

Read the official FDA notice

Published
18 Jun 2025
Units affected
1,344- 1000 count bottles
Agency
FDA
Country
United States

The hazard

Presence of a foreign substance: black hair found embedded in tablet.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.

Brand / company
Macleods Pharmaceuticals Ltd
Codes / lots
Lot #: MLF2401A, Exp 01/31/2026
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 18 Jun 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.